AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer

Recruitingn/aAges 5 Years - anyAllSt. Jude Children's Research Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Childhood cancer predisposes to health risks that may not become apparent until many years after completion of therapy. The SJLIFE protocol is designed to establish a lifetime cohort of childhood cancer survivors treated at St. Jude Children's Research Hospital to facilitate evaluation of health outcomes in aging adults surviving pediatric cancer. The study focuses on the following Primary and secondary objectives: * To establish a lifetime cohort of childhood cancer survivors treated at St. Jude Children's Research Hospital to facilitate evaluation of health outcomes in aging children and adults surviving pediatric cancer. * To estimate the prevalence, cumulative incidence, and latency of selected late treatment complications following predisposing therapeutic exposures in children and adults surviving pediatric cancer. * To identify treatment, demographic, and psychosocial / behavior

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Survivor Inclusion Criteria: * Patient will have a diagnosis of childhood malignancy (or neoplasm requiring similar therapy) that was treated or followed at St. Jude Children's Research Hospital. * Patient will be at least five years from diagnosis. * Patient is willing to participate at any level of study * Patient is willing to comply with the guidelines of St. Jude domiciliary care facilities * Patient or legally authorized representative must sign informed consent for study participation. Control Participant Inclusion Criteria: * โ‰ฅ5 years of age * Non-first degree relatives or friends of St. Jude patients or former patients or SJCRH employees/affiliates who are not SJLIFE study team members, or family members of SJLIFE study team, or supervised by a SJLIFE study team members, or any volunteer not associated with St. Jude. * Participant does not have a diagnosis of childhood malignancy or childhood neoplasm requiring similar therapy (i.e., diagnosed \<21 years of age). * Participant is not currently pregnant or lactating. * Patient is willing to comply with the guidelines of St. Jude domiciliary care facilities. * Patient must sign informed consent for study participation. Gait and Mobility Lab Assessment Inclusion Criteria: * Enrolled participant in the SJLIFE study. * At-risk for long lasting difficulties with walking or other aspects of mobility. * Participant is not currently pregnant. * Participant or their designee signs informed consent for Gait and Mobility Lab Assessment participation. Survivor/Control Exclusion Criteria: * Patient or control subject refuses to participate at any level of study Gait and Mobility Lab Assessment Exclusion Criteria: * Prospective participant or their designee declines participation in the Gait and Mobility Lab Assessment.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
St. Jude Children's Research Hospital
Memphis, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy